Should I invest in UTI Corporate Bond Fund - Annual IDCW?

We don't give personal investment advice. UTI Corporate Bond Fund - Direct Plan - Annual IDCW is suitable for an investor whose:time horizon matches the fund's modified duration — short-duration funds for 1-3 year goals, long-duration for 7+ yearsprimary goal is capital preservation or steady accrual, not high growthtax slab is moderate — high-slab investors should evaluate post-tax yield against tax-free alternatives (PPF, tax-free bonds)Cross-check the numbers above against alternatives before deciding. Worst 5-year drawdown: 3.8%. 5-year CAGR: 3.13%.

UTI

UTI Corporate Bond Fund - Direct Plan - Annual IDCW

Latest NAV

₹13.6073

As of

3 Jun 2026

1,886 NAV records on file

NAV history & peer comparison

All NAVs split-adjusted and normalised to 100 at the start of the selected period, so funds with very different absolute NAV scales can be compared on one axis.

Period

Add another fund to compare

No matches.

Compares up to 8 funds. Click any line in the legend above to hide/show it.

Returns matrix

Fund return alongside the category average and peer rank for every standard window. Returns under one year are absolute; one year and longer are compound annualised (CAGR).

Window	Fund	Category avg	+/− vs avg	Rank	Quartile
1D	+0.06%	+14.97%	-14.90	44 / 72	Q3
1W	+0.26%	+15.14%	-14.88	35 / 72	Q2
2W	+0.36%	+15.28%	-14.92	42 / 72	Q3
1M	+0.16%	+15.20%	-15.03	28 / 72	Q2
3M	-2.45%	+14.82%	-17.27	62 / 72	Q4
6M	-1.53%	+15.94%	-17.47	52 / 71	Q3
YTD	-1.70%	+15.04%	-16.74	60 / 71	Q4
1Y	+1.03%	+17.89%	-16.86	28 / 71	Q2
2Y	+3.50%	+5.94%	-2.45	28 / 71	Q2
3Y	+3.36%	+2.32%	+1.04	24 / 66	Q2
4Y	+3.74%	+2.56%	+1.18	21 / 61	Q2
5Y	+3.13%	+1.49%	+1.65	15 / 52	Q2
7Y	+3.66%	+1.91%	+1.75	14 / 50	Q2
10Y	—	—	—	—	—
Inception	+4.01%	+6.36%	-2.35	24 / 67	Q2

Quartile legend: Q1 top 25% Q2 25-50% Q3 50-75% Q4 bottom 25%

Calendar-year returns

Full-year performance vs category average. Current year is partial (year-to-date).

Year	Fund	Category avg	+/− vs avg	Rank
2026 YTD	-1.70%	-0.52%	-1.18	48 / 58
2025	+4.14%	+3.04%	+1.10	22 / 61
2024	+4.04%	+3.39%	+0.64	24 / 62
2023	+5.23%	+2.73%	+2.51	18 / 60
2022	+1.57%	+19.77%	-18.20	22 / 61
2021	-1.41%	-1.89%	+0.48	34 / 54
2020	+7.38%	+4.23%	+3.15	12 / 50
2019	+9.68%	+2.75%	+6.93	6 / 47
2018	—	—	—	—

Rolling returns

Removes start-date bias by averaging CAGR over every overlapping N-year window in the fund's history. Higher average plus tight min/max plus high "% positive" = consistent.

1-Year rolling

+4.29%

84 windows

min -1.3% · max 11.2%

93% positive

3-Year rolling

+3.50%

59 windows

min 1.7% · max 6.0%

100% positive

Limited basis — fund is young, so this average may be skewed by which 3Y windows happen to be available.

5-Year rolling

+3.51%

35 windows

min 2.7% · max 4.6%

100% positive

Limited basis — fund is young, so this average may be skewed by which 5Y windows happen to be available.

7-Year rolling

+4.24%

11 windows

min 3.7% · max 4.6%

100% positive

Limited basis — fund is young, so this average may be skewed by which 7Y windows happen to be available.

SIP returns — historical "what if"

If you had invested every month in this fund over the chosen period, this is what your investment would be worth today.

Period

Total invested

₹ —

Today's value

₹ —

XIRR

Annualised

Wealth multiplier

Period	Total invested	Today's value	XIRR	Wealth multiplier

XIRR is the annualised internal rate of return on the SIP cash flow — invariant to the monthly amount. "Today's value" and "Total invested" scale linearly with the slider. Past performance does not guarantee future returns. Excludes exit load and taxes.

Risk profile

Risk-adjusted return and volatility, computed from monthly NAV returns over the trailing 3-year and 5-year windows.

Std deviation

3.54%

3-year · annualised

Sharpe ratio

-0.88

vs risk-free 6.5%

Sortino ratio

-1.05

Downside-only deviation

Max drawdown

-3.85%

Mar 2024 → Mar 2024

% positive months

86.1%

Share of monthly returns > 0 over the 3-year window

Sharpe / Sortino use a risk-free rate of 6.5% (1-year T-bill proxy). Higher Sharpe = more return per unit of total risk; higher Sortino = more return per unit of downside risk.

Peers in Corporate Bond Fund

Scheme	Fund house	NAV	As of
HDFC Corporate Bond Fund - IDCW Option - Direct Plan	HDFC	₹21.0823	3 Jun 2026
NIPPON INDIA CORPORATE BOND FUND - DIRECT Plan - DAILY IDCW Option	Nippon India	₹17.0800	3 Jun 2026
SBI Corporate Bond Fund - Direct Plan - Monthly Income Distribution cum Capital Withdrawal Option (IDCW)	SBI	₹15.6984	3 Jun 2026
ICICI Prudential Corporate Bond Fund - Direct Plan - Monthly IDCW	ICICI Prudential	₹10.2250	3 Jun 2026
Invesco India Corporate Bond Fund - Direct Plan - Annual IDCW (Payout / Reinvestment)	Invesco	₹1,216.0142	3 Jun 2026
BANDHAN Corporate Bond Fund - Direct Annual IDCW	Bandhan	₹10.3094	3 Jun 2026
Aditya Birla Sun Life Corporate Bond Fund -DIRECT - IDCW	Aditya Birla Sun Life	₹10.4102	3 Jun 2026
Franklin India Corporate Debt Fund - Plan A - Direct - Annual - IDCW	Franklin India	₹18.7176	3 Jun 2026
Mirae Asset Corporate Bond Fund Direct IDCW	Mirae Asset	₹13.5152	3 Jun 2026
Kotak Corporate Bond Fund- Direct Plan- Monthly Payout of Income Distribution cum capital withdrawal option	Kotak	₹1,071.7888	3 Jun 2026

Recent NAVs

Date	NAV
3 Jun 2026	₹13.6073
2 Jun 2026	₹13.6090
1 Jun 2026	₹13.6005
29 May 2026	₹13.5972
27 May 2026	₹13.5831
26 May 2026	₹13.5735
25 May 2026	₹13.5716
22 May 2026	₹13.5476
21 May 2026	₹13.5383
20 May 2026	₹13.5532

Frequently asked questions

These answers are generated from this fund's live metrics — NAV, returns, peer rank, drawdown, SIP backtest. Numbers refresh nightly after AMFI's NAV feed lands.

As of 03 Jun 2026, the NAV of UTI Corporate Bond Fund - Direct Plan - Annual IDCW is ₹13.6073. It's a Corporate Bond Fund from UTI, run as a Direct plan IDCW (dividend) option. NAVs update once per business day from the AMFI feed.

UTI Corporate Bond Fund - Direct Plan - Annual IDCW has NAV history starting from 09 Aug 2018, a track record of about 7 years 9 months. That's enough history to evaluate the fund across one or two market cycles. Look at rolling returns rather than point-to-point to judge consistency.

UTI Corporate Bond Fund - Direct Plan - Annual IDCW is managed by UTI. It's classified by AMFI under the 'Corporate Bond Fund' SEBI category, which determines its peer set and tax treatment.

Over the trailing 1-year window, UTI Corporate Bond Fund - Direct Plan - Annual IDCW has delivered a absolute return of 1.03% — -16.86 pp behind the Corporate Bond Fund category average of 17.89%. The fund ranks #28 of 71 in its category — the second (Q2) quartile.

Over the trailing 3-year window, UTI Corporate Bond Fund - Direct Plan - Annual IDCW has delivered a CAGR of 3.36% — +1.04 pp ahead of the Corporate Bond Fund category average of 2.32%. The fund ranks #24 of 66 in its category — the second (Q2) quartile.

Over the trailing 5-year window, UTI Corporate Bond Fund - Direct Plan - Annual IDCW has delivered a CAGR of 3.13% — +1.65 pp ahead of the Corporate Bond Fund category average of 1.49%. The fund ranks #15 of 52 in its category — the second (Q2) quartile.

₹1 lakh invested in UTI Corporate Bond Fund - Direct Plan - Annual IDCW exactly 5 years ago would be worth approximately ₹116,675 today — a multiplier of 1.17×, based on the 5-year CAGR of 3.13%. The category average over the same window would have grown ₹1 lakh to ₹107,656.

A ₹10,000 monthly SIP in UTI Corporate Bond Fund - Direct Plan - Annual IDCW over the last 5 years — total invested ₹600,000 — would be worth ₹647,401 today. That's an XIRR (money-weighted annualised return) of 3.00%.

UTI Corporate Bond Fund - Direct Plan - Annual IDCW doesn't yet have 10 years of NAVs. Over the longest available window (7-year SIP), ₹10,000/month would have grown to ₹932,924 — XIRR 2.96%.

On a 5-year basis, UTI Corporate Bond Fund - Direct Plan - Annual IDCW ranks #15 out of 52 funds in the Corporate Bond Fund category — that places it in the second quartile (Q2) — above the median. The category average return over the same window is 1.49%; this fund delivered 3.13%.

The worst peak-to-trough decline UTI Corporate Bond Fund - Direct Plan - Annual IDCW has experienced over the last 5-year window is 3.85% — its NAV fell from a high on 15 Mar 2024 to a low on 19 Mar 2024. Drawdown is a useful gauge of how much short-term pain you'd have endured to capture the long-term return.

Across all 5-year rolling windows, UTI Corporate Bond Fund - Direct Plan - Annual IDCW averaged 3.51% (best 4.64%, worst 2.68%). 100% of rolling windows ended positive. The 5-year Sharpe ratio is -1.11 — negative risk-adjusted performance.

In calendar year 2025, UTI Corporate Bond Fund - Direct Plan - Annual IDCW returned 4.14% — beating the Corporate Bond Fund category average of 3.04% by 1.10 pp. It ranked #22 of 61 in its category that year.

UTI Corporate Bond Fund - Direct Plan - Annual IDCW is classified as a Debt fund. For units acquired on or after 1 April 2023, all gains are taxed at your income-tax slab rate regardless of holding period — there's no LTCG concession or indexation. For pre-April-2023 units, the old rules with indexation still apply on long-term gains.

We don't give personal investment advice. UTI Corporate Bond Fund - Direct Plan - Annual IDCW is suitable for an investor whose:

time horizon matches the fund's modified duration — short-duration funds for 1-3 year goals, long-duration for 7+ years
primary goal is capital preservation or steady accrual, not high growth
tax slab is moderate — high-slab investors should evaluate post-tax yield against tax-free alternatives (PPF, tax-free bonds)

Cross-check the numbers above against alternatives before deciding. Worst 5-year drawdown: 3.8%. 5-year CAGR: 3.13%.

Educational content only — not investment advice. Tax rules summarised above reflect Budget 2024; consult a qualified adviser before transacting.

UTI Corporate Bond Fund - Direct Plan - Annual IDCW

NAV history & peer comparison

Returns matrix

Calendar-year returns

Rolling returns

SIP returns — historical "what if"

Risk profile

Peers in Corporate Bond Fund

Recent NAVs

Frequently asked questions

More from UTI